Article · 13 Feb 2026
Conference abstractPublished 23 Nov 2012
Development of sustained release tablet of verapamil HCl using natural polymers
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Advancement in development of sustained-release drug delivery systems is use of polymer of natural origin to fulfill the aim of sustaining the drug release. Aim of present study was to develop sustained release tablet of Verapamil HCl using natural polymers such as Locust bean gum (LBG) and Xanthan gum (XG). Different batches of SR tablet were prepared using various concentrations of LBG, XG and combination of both. Prepared tablets were evaluated for various parameters like hardness, friability, uniformity of weight, uniformity of drug content, swelling behavior, drug-polymer interaction, in-vitro drug release and short term stability studies. In-vitro drug release studies were performed using USP XXIII apparatus-I at 100 rpm. The results of in-vitro drug release showed that as concentration of polymer increases drug release retardation also increase. It was also found that formulations containing Xanthan gum retard more drug than that of formulation containing Locust bean gum. Formulation containing combination of both LBG and XB showed required drug release which was compared with marketed formulation. It was may be due to synergistic effect of both polymer. Short term stability study of optimized formulation showed that formulation was stable at respective temperature and humidity condition. Study concluded that it is possible to make once a day sustained release tablet of Verapamil HCl using natural polymer such as Locust bean gum and Xanthan gum
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “T. A. Mullani”
- BylineArticles whose byline prints “D. A. Bhagwat”
- BylineArticles whose byline prints “A. K. Mullani”
- BylineArticles whose byline prints “J. I. D’Souza”
